Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Boheler

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Proteomics|August 12, 2011
Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biologyRebekah L Gundry, Paul W Burridge, Kenneth R Boheler
Bioinformatics (Oxford, England)|March 4, 2003
Can transcriptome size be estimated from SAGE catalogs?Michael D Stern, Sergey V Anisimov, Kenneth R Boheler
Stem Cells International|December 23, 2011
Stem cells in heart failureGabriela Kania, Kenneth R Boheler, Ulf Landmesser, et al.
Cardiovascular Research|April 12, 2005
Aging-associated changes in cardiac gene expressionMaria Volkova, Rahul Garg, Salihah Dick, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 22, 2017
Discovery of Surface Target Proteins Linking Drugs, Molecular Markers, Gene Regulation, Protein Networks, and Disease by Using a Web-Based Platform Targets-searchBin Yan, Panwen Wang, Junwen Wang, et al.
Pflugers Archiv : European Journal of Physiology|June 16, 2021
Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapyKenneth R Boheler, Albano C Meli, Huang-Tian Yang
Plos One|December 11, 2008
Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastomaSatoshi Yamanaka, Ihor Zahanich, Robert P Wersto, et al.
Stem Cell Research|February 3, 2026
Generation of an induced pluripotent stem cell line, JHUi006-A, from a Marfan Syndrome patient harboring a pathogenic c.5225-2A > C intronic splicing variantFranklyn D Hall, Christine Miller, Sharon Gerecht, et al.
Drug Discovery Today. Disease Models|May 18, 2013
Human ESC/iPSC-based "Omics" and Bioinformatics for Translational ResearchGerd Müller, Kirill V Tarasov, Rebekah L Gundry, et al.
Stem Cell Research|June 28, 2024
Generation of an induced pluripotent stem cell line, JHUi005-A, from a Marfan Syndrome patient harboring a pathogenic c.3338-2A>C intronic splicing variantFranklyn D Hall, Christine N Miller, Sharon Gerecht, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Proteomics|August 12, 2011
Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biologyRebekah L Gundry, Paul W Burridge, Kenneth R Boheler
Bioinformatics (Oxford, England)|March 4, 2003
Can transcriptome size be estimated from SAGE catalogs?Michael D Stern, Sergey V Anisimov, Kenneth R Boheler
Stem Cells International|December 23, 2011
Stem cells in heart failureGabriela Kania, Kenneth R Boheler, Ulf Landmesser, et al.
Cardiovascular Research|April 12, 2005
Aging-associated changes in cardiac gene expressionMaria Volkova, Rahul Garg, Salihah Dick, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 22, 2017
Discovery of Surface Target Proteins Linking Drugs, Molecular Markers, Gene Regulation, Protein Networks, and Disease by Using a Web-Based Platform Targets-searchBin Yan, Panwen Wang, Junwen Wang, et al.
Pflugers Archiv : European Journal of Physiology|June 16, 2021
Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapyKenneth R Boheler, Albano C Meli, Huang-Tian Yang
Plos One|December 11, 2008
Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastomaSatoshi Yamanaka, Ihor Zahanich, Robert P Wersto, et al.
Stem Cell Research|February 3, 2026
Generation of an induced pluripotent stem cell line, JHUi006-A, from a Marfan Syndrome patient harboring a pathogenic c.5225-2A > C intronic splicing variantFranklyn D Hall, Christine Miller, Sharon Gerecht, et al.
Drug Discovery Today. Disease Models|May 18, 2013
Human ESC/iPSC-based "Omics" and Bioinformatics for Translational ResearchGerd Müller, Kirill V Tarasov, Rebekah L Gundry, et al.
Stem Cell Research|June 28, 2024
Generation of an induced pluripotent stem cell line, JHUi005-A, from a Marfan Syndrome patient harboring a pathogenic c.3338-2A>C intronic splicing variantFranklyn D Hall, Christine N Miller, Sharon Gerecht, et al.
Pageof 12